Stay updated on Setmelanotide in Early-Onset POMC Deficiency Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in Early-Onset POMC Deficiency Obesity Clinical Trial page.

Latest updates to the Setmelanotide in Early-Onset POMC Deficiency Obesity Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov record for the setmelanotide study in early-onset POMC/PCSK1 deficiency obesity is displayed, including study details, participation criteria, locations, outcome measures, and related documents.SummaryDifference54%

- Check8 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check15 days agoChange DetectedA notice about NIH’s terminology transition appears above the ClinicalTrials.gov study-record error page.SummaryDifference1%

- Check22 days agoChange DetectedThe ClinicalTrials.gov study page still displays a 403 Forbidden error. Its footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the study page still shows a 403 Forbidden error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the normal study record content and making several study documents and related metadata inaccessible on this page.SummaryDifference19%

Stay in the know with updates to Setmelanotide in Early-Onset POMC Deficiency Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in Early-Onset POMC Deficiency Obesity Clinical Trial page.